Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function

被引:108
作者
Cappelleri, JC
Siegel, RL
Osterloh, IH
Rosen, RC
机构
[1] Pfizer Inc, Global Res & Dev, Dept Clin Res, Groton, CT 06340 USA
[2] Pfizer Inc, Pharmaceut Grp, New York, NY USA
[3] Pfizer Ltd, Pharmaceut Grp, Sandwich CT13 9NJ, Kent, England
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ USA
关键词
D O I
10.1016/S0090-4295(00)00697-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To assess the validity of severity classes on the erectile function (EF) domain of the International Index of Erectile Function by determining their relationship with the self-assessment of EF, before and after treatment, in an independent cohort of patients, Methods. Two hundred forty-seven men with clinically diagnosed erectile dysfunction (ED) and in a stable heterosexual relationship were enrolled in a randomized, double-blind, multicenter, placebo-controlled, parallel-group, 12-week, flexible-dose study. Patients assessed their degree of ED as severe, moderate, minimal/mild, or no problem at baseline and after treatment. They also responded to the six questions of the EF domain, with the total score indicating the following degrees of ED: severe, EF score 1 to 10; moderate, EF score 11 to 16, mild to moderate, EF score 17 to 21; mild, EF score 22 to 25; and no ED, EF score 26 to 30. Descriptive profiles of the two diagnostic instruments were compared. The correlations between the instruments were evaluated with Kendall's tau-b at baseline, after treatment at 12 weeks, and at change from baseline. Results. The two measures gave generally similar descriptive profiles of ED severity. The correlations were 0.65 (95% confidence interval 0.57 to 0.73) at baseline, 0.86 (95% confidence interval 0.83 to 0.89) after 12 weeks of treatment, and 0.73 (95% confidence interval 0.67 to 0.79) at change from baseline. Conclusions. The moderate-to-high correlation between the patients' self-assessment of EF and the EF domain of the International Index of Erectile Function provides a validation of this domain for the reliable diagnostic classification of ED severity. UROLOGY 56: 477-481, 2000. (C) 2000, Elsevier Science Inc.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 18 条
[1]   IS THERE A RELIABLE AND VALID SELF-REPORT MEASURE OF SEXUAL-BEHAVIOR [J].
ANDERSEN, BL ;
BROFFITT, B .
ARCHIVES OF SEXUAL BEHAVIOR, 1988, 17 (06) :509-525
[2]  
BENNETT C, 1999, 1 INT CONS ER DYSF
[3]  
BORKON W, 1999, 1 INT CONS ER DYSF P
[4]  
Broderick GA, 1998, INT J IMPOT RES, V10, pS64
[5]   Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function [J].
Cappelleri, JC ;
Rosen, RC ;
Smith, MD ;
Mishra, A ;
Osterloh, IH .
UROLOGY, 1999, 54 (02) :346-351
[6]  
Cappelleri JC, 1999, DRUG INF J, V33, P179, DOI 10.1177/009286159903300122
[8]  
DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
[9]   CONSTRUCTION OF A SURROGATE VARIABLE FOR IMPOTENCE IN THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (05) :457-467
[10]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61